荷尔蒙避孕药与生殖年龄组妇女抑郁症的关联:一个横断分析研究
Sadia Sultan1, Md Abu Bashar2, Rahma M Bazhair1
1Clinical Science Department-MBBS Program Fakeeh College for Medical Sciences, Jeddah, Saudi Arabia.
Obstetrics and gynecology international
|September 30, 2024
概括
荷尔蒙避孕药 (HCs) 在整体抑郁症得分上没有显著差异. 然而,一些个人抑郁症状在使用HC的女性中更为普遍,这表明存在潜在的联系.
科学领域:
- 生殖健康 生殖健康
- 心理健康 心理健康
- 药理学 药理学是指药理学的学科.
背景情况:
- 激素避孕药 (HCs) 广泛用于节育和治疗妇科疾病.
- 情绪变化是停止HCs的常见原因之一.
- 现有的关于HCs与抑郁症之间的关联的研究产生了不同的结果.
研究的目的:
- 调查使用荷尔蒙避孕药与抑郁症状之间的关联.
- 为了确定使用荷尔蒙避孕药是否与抑郁症的风险或严重程度增加有关.
主要方法:
- 一项涉及沙特阿拉伯326名年龄在15-49岁的女性的横截面研究.
- 收集的数据包括社会人口统计,避孕药的使用 (荷尔蒙,非荷尔蒙,没有) 和使用时间.
- 使用贝克抑郁 inventory-II (BDI-II) 评估抑郁症状,得分>16表明临床抑郁.
主要成果:
- 在荷尔蒙避孕药使用者和不使用者之间,没有发现平均BDI得分或整体抑郁症严重程度的显著差异 (分别为p=0.79和p=0.06).
- 在荷尔蒙避孕药使用者中,观察到明显更高的特定抑郁症状,包括悲伤 (p=0.01),性欲下降 (p=0.0002),悲观 (p=0.02) 和失败感 (p=0.003).
- 显著比例的参与者 (50.6%) 是当前使用荷尔蒙避孕药的.
结论:
- 虽然整体抑郁症得分没有显著差异,但使用荷尔蒙避孕药与某些个人抑郁症状的发病率更高有关.
- 这些发现表明,与抑郁症相关的症状可能是使用荷尔蒙避孕药的潜在,尽管是特定的副作用.
- 需要进一步的研究来阐明荷尔蒙避孕药与心理健康的特定方面之间的细微关系.
更多相关视频
06:55An Unpredictable Chronic Mild Stress Protocol for Instigating Depressive Symptoms, Behavioral Changes and Negative Health Outcomes in Rodents
Published on: December 2, 2015
22.4K
05:36Herbs-Partitioned Moxibustion on the Navel in a Rat Model of Primary Dysmenorrhea with Cold Coagulation and Blood Stasis
Published on: October 4, 2024
465
相关概念视频
01:22Hormonal Regulation of the Menstrual Cycle
312
The ovarian cycle regulates endometrial changes throughout a single menstrual cycle via the coordinated action of gonadotrophin-releasing hormone (GnRH) and gonadotrophins.
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH...
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH...
312
01:24Disorders of the Female Reproductive System
333
The female reproductive system can be affected by several disorders, including Premenstrual Syndrome (PMS), Premenstrual Dysphoric Disorder (PMDD), endometriosis, and various forms of cancer. PMS and PMDD are cyclical conditions that cause physical and emotional distress, with symptoms that include edema, mood swings, and food cravings. PMDD is a more severe form of PMS characterized by increased symptom severity that peaks during the luteal phase and tends to improve or resolve shortly after...
333
01:30Hormonal Control of the Ovarian Cycle
438
The ovarian cycle is meticulously regulated by the hypothalamic-pituitary-gonadal axis. This cycle orchestrates the release of a mature oocyte, essential for reproduction.
Before puberty, the hypothalamus releases GnRH in a low frequency, low amplitude pulsatile manner. This along with the immature hypothalamic-pituitary-gonadal axis activity, results in low estrogen levels and the absence of a fully functional ovarian cycle. At puberty, GnRH secretion increases in both frequency and...
Before puberty, the hypothalamus releases GnRH in a low frequency, low amplitude pulsatile manner. This along with the immature hypothalamic-pituitary-gonadal axis activity, results in low estrogen levels and the absence of a fully functional ovarian cycle. At puberty, GnRH secretion increases in both frequency and...
438
01:28Menopause
143
Menopause, a natural biological process marking the end of a woman's fertility, typically occurs between the fifth and sixth decade of life. This phase is characterized by the exhaustion of the ovarian follicle pool, leading to less responsive ovaries despite the high levels of Follicle Stimulating Hormone (FSH) and Luteinizing Hormone (LH). The consequential decrease in estrogen production results in symptoms like hot flashes, heavy sweating, headaches, hair loss, muscle pains, vaginal...
143
01:18Depression: Overview
224
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
224
01:23Antidepressant Drugs: MAOIs and Other Agents
200
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
200